Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Rathbone Share News (RAT)
RAT Share
Price
RAT Share
News
RAT Share
Chat
RAT Share
Trades599
RAT
Live RNS
RAT Share
Charts
RAT Level 2
Console
RAT Live
Share Price
RAT Broker
Ratings
RAT Directors
Deals
RAT Financial
Diary
RAT
Fundamentals
RAT Short
Positions
RAT
Media
RAT Company
Research
RAT Company
Timeline
Share Price Information for Rathbone (RAT)
Last checked at -
Last checked at 
Intraday Rathbone Share Chart
Thursday broker round-up
Hochschild Mining: Berenberg reiterates hold with a target price of 190p.
Morgan Sindall: Liberum reiterates hold with a target price of 1,850p.
Spectris: Liberum reiterates hold with a target price of 2,400p.
Rathbone Brothers: Liberum reiterates hold with a target price of 2,100p.
Mondi: Deutsche Bank reiterates buy with a target price of 1,950p.
Meggitt: Credit Suisse reiterates underperform with a target price of 520p.
AstraZeneca: Barclays reiterates overweight with a target price of 8,500p.
GlaxoSmithKline: Barclays reiterates underweight with a target price of 1,550p.
Hikma Pharmaceuticals: Barclays reiterates equal weight with a target price of 1,900p.
Latest RAT News
- PRESS: Rathbones merger with Investec UK slowed regulatory checks - FT
18 Jun 2026 - LONDON BROKER RATINGS: Berenberg cuts Anglo American, raises Valterra
18 Jun 2026 - WINNERS & LOSERS: Hays refocuses on core markets; Weir wins contract
17 Jun 2026 - LONDON BROKER RATINGS: Wedbush starts Flutter at 'outperform'
17 Jun 2026 - IN BRIEF: Rathbones starts share buyback after profit warning
17 Jun 2026 - DIRECTOR DEALINGS: Rathbones Chair & CEO pick up shares after warning
16 Jun 2026 - LONDON MARKET CLOSE: Financials lift FTSE 100 as oil heads below USD80
16 Jun 2026 - Director dealings: Rathbones leaders purchase shares amid FCA‑related review
16 Jun 2026
Related News
LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears
(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike...
Hutchmed drug approved in China for advanced gastric cancer
(Alliance News) - Hutchmed China Ltd on Thursday announced regulatory approval for savolitinib, brand name 'ORPATHYS', for a form of gastric cancer wi...
Rathbone News
PRESS: Rathbones merger with Investec UK slowed regulatory checks - FT
(Alliance News) - Rathbones Group PLC was distracted from implementing consumer finance regulations by the work required for its merger with the UK we...
LONDON BROKER RATINGS: Berenberg cuts Anglo American, raises Valterra
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:
WINNERS & LOSERS: Hays refocuses on core markets; Weir wins contract
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.
LONDON BROKER RATINGS: Wedbush starts Flutter at 'outperform'
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:
IN BRIEF: Rathbones starts share buyback after profit warning
Rathbones Group PLC - London-based investment and wealth manager - Starts on Wednesday the GBP20 million share buyback announced in February with its ...
DIRECTOR DEALINGS: Rathbones Chair & CEO pick up shares after warning
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separatel...
LONDON MARKET CLOSE: Financials lift FTSE 100 as oil heads below USD80
(Alliance News) - The FTSE 100 made strong progress on Tuesday as oil fell further amid growing confidence in the US-Iran peace process.
Director dealings: Rathbones leaders purchase shares amid FCA‑related review
(Sharecast News) - Rathbones Group revealed on Tuesday that chairman Clive Bannister and chief executive Jonathan Sorrell had both spent roughly £...
Follow the stocks
